Randomizing the parameters of a Markov chain to model the stroke disease: A technical generalization of established computational methodologies towards improving real applications

Briggs, 1998, An introduction to Markov modelling for economic evaluation, PharmacoEconomics, 13, 397, 10.2165/00019053-199813040-00003 Sonnenberg, 1993, Markov models in medical decision making: a practical guide, Med. Decis. Making, 13, 322, 10.1177/0272989X9301300409 Cooper, 2004, The analysis of hospital infection data using hidden Markov models, Biostatistics, 5, 223, 10.1093/biostatistics/5.2.223 Mandel, 2008, Estimating time-to-event from longitudinal ordinal data using random-effects Markov models: application to multiple sclerosis progression, Biostatistics, 9, 750, 10.1093/biostatistics/kxn008 Mar, 2008, Calculation of prevalence with Markov models: Budget impact analysis of thrombolysis for stroke, Med. Decis. Making, 28, 481, 10.1177/0272989X07312720 Korostil, 2012, Adaptive Markov chain Monte Carlo forward projection for statistical analysis in epidemic modelling of human papilloma virus, Stat. Med., 32, 1917, 10.1002/sim.5590 Mar, 2010, Los modelos de Markov probabilísticos en la evaluación económica de tecnologías sanitarias: una guía práctica, Gac. Sanit., 24, 209, 10.1016/j.gaceta.2010.02.006 Pan, 2007, A Markov regression random-effects model for remission of functional disability in patients following a first stroke: A Bayesian approach, Stat. Med., 26, 5335, 10.1002/sim.2999 Kapetanakis, 2013, A semi-Markov model for stroke with piecewise-constant hazards in the presence of left, right and interval censoring, Stat. Med., 32, 697, 10.1002/sim.5534 Zhang, 1998, What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes, JAMA, 290, 1690, 10.1001/jama.280.19.1690 McNutt, 2003, Estimating the relative risk in cohort studies and clinical trials of common outcomes, Am. J. Epidemiol., 157, 940, 10.1093/aje/kwg074 Soong, 1973 Kegan, 2005, Modeling the simple epidemic with deterministic differential equations and random initial conditions, Math. Biosci., 195, 179, 10.1016/j.mbs.2005.02.004 Casabán, 2015, Probabilistic solution of random SI-type epidemiological models using the Random Variable Transformation technique, Commun. Nonlinear Sci. Numer. Simul., 24, 86, 10.1016/j.cnsns.2014.12.016 Casabán, 2016, A comprehensive probabilistic solution of random SIS-type epidemiological models using the Random Variable Transformation technique, Commun. Nonlinear Sci. Numer. Simul., 32, 199, 10.1016/j.cnsns.2015.08.009 Dorini, 2016, On the logistic equation subject to uncertainties in the environmental carrying capacity and initial population density, Commun. Nonlinear Sci. Numer. Simul., 33, 160, 10.1016/j.cnsns.2015.09.009 Prieto, 2004, Análisis coste-efectividad en la evaluación económica de intervenciones sanitarias, Med. Clin., 122, 505, 10.1016/S0025-7753(04)74288-8 Karlsson, 1996, The decision rules of cost-effectiveness analysis, PharmacoEconomics, 9, 113, 10.2165/00019053-199609020-00003 Hazen, 2011, Cohort decomposition for Markov cost-effectiveness models, Med. Decis. Making, 31, 19, 10.1177/0272989X10368999 Pinto-Prades, 2001, Análisis coste-utilidad, Aten. Primaria, 27, 569, 10.1016/S0212-6567(01)78861-0 Badia, 2005, Análisis de la relación coste-efectividad a corto y largo plazo de clopidogrel añadido a terapia estándar en pacientes con síndrome coronario agudo en España, Rev. Esp. Cardiol., 58, 1385, 10.1016/S0300-8932(05)74068-9 Antoñanzas, 2011, Cost-effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain, Actas Urol. Esp., 35, 65, 10.1016/j.acuro.2010.11.008 Sacristán, 2002, Qué es una tecnología sanitaria eficiente en España?, Gac. Sanit., 4, 334, 10.1016/S0213-9111(02)71933-X